BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34363463)

  • 21. IgG4-related disease: How to place it in the spectrum of immune-mediated and rheumatologic disorders?
    Borges T; Silva S
    Mod Rheumatol; 2020 Jul; 30(4):609-616. PubMed ID: 31852351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Guo X; Shioya A; Mizutani KI; Kumagai M; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Nakamura S; Yamada S
    Pathol Res Pract; 2019 Oct; 215(10):152563. PubMed ID: 31358479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyper-IL-6 syndrome mimicking IgG4-related disease].
    Terao T; Yamamoto K; Ikeuchi K; Wakabayashi H; Igawa T; Inoue D; Oda W; Oyama T; Kamoi C; Sumii Y; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Sato Y; Yoshino T; Imajo K
    Rinsho Ketsueki; 2019; 60(5):392-397. PubMed ID: 31168001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy.
    Liu B; Huang Y; Tang L; Guan J; Zhou X; Zhan H
    Diagn Pathol; 2021 Aug; 16(1):74. PubMed ID: 34376196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
    Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
    Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Zen Y
    Presse Med; 2020 Apr; 49(1):104014. PubMed ID: 32234381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG4-Related Lymphadenopathy.
    Sato Y; Yoshino T
    Int J Rheumatol; 2012; 2012():572539. PubMed ID: 22719769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic dilemma of IgG4-related primary localized cervical lymphadenopathy associated with aberrant IL-6 expression level.
    Nakamura M; Iwamoto O; Chino T; Todoroki K; Kusukawa J
    Diagn Pathol; 2016 May; 11(1):43. PubMed ID: 27142509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
    Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
    Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
    Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in IgG4-related kidney disease.
    Kawano M; Saeki T; Ubara Y; Matsui S
    Mod Rheumatol; 2023 Mar; 33(2):242-251. PubMed ID: 35788361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium.
    Sawada E; Shioda Y; Ogawa K; Iwashita T; Ono Y; Hasegawa H; Maeshima A
    Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
    Koga T; Sumiyoshi R; Kawakami A; Yoshizaki K
    Mod Rheumatol; 2019 Mar; 29(2):302-305. PubMed ID: 30285516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin G4-related hepatobiliary disease.
    Lee HE; Zhang L
    Semin Diagn Pathol; 2019 Nov; 36(6):423-433. PubMed ID: 31358425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG4-related lymphadenopathy.
    Cheuk W; Bledsoe JR
    Semin Diagn Pathol; 2024 Mar; 41(2):108-115. PubMed ID: 38228439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and pitfalls in the diagnosis of IgG4-related disease.
    Bateman AC; Culver EL
    Semin Diagn Pathol; 2024 Mar; 41(2):45-53. PubMed ID: 38000975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature.
    Kawashima H; Utsugi A; Shibamiya A; Iida K; Mimura N; Ohashi H; Hase R; Kawakami M; Yanagisawa T; Hiraguri M
    Immunol Res; 2019 Feb; 67(1):99-107. PubMed ID: 30734199
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Zongfei J; Rongyi C; Xiaomeng C; Lili M; Lingying M; Xiufang K; Xiaomin D; Zhuojun Z; Huiyong C; Ying S; Lindi J
    Front Immunol; 2020; 11():1272. PubMed ID: 32733444
    [No Abstract]   [Full Text] [Related]  

  • 39. IgG4-related disorder of the retroperitoneum resembling Castleman's disease plasma cell type: a report of 2 cases.
    Kojima M; Nakamura N; Motoori T; Shimizu K; Haratake J; Nakamura S
    Int J Surg Pathol; 2011 Apr; 19(2):220-4. PubMed ID: 19372084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases.
    Otoshi R; Kitamura H; Baba T; Muraoka T; Sekine A; Takemura T; Okudela K; Sawazumi T; Ogura T
    Respir Investig; 2024 Jan; 62(1):1-8. PubMed ID: 37925882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.